Future prospective studies must address whether targeting the IL-5 pathway alone is sufficient and we speculate that IL-13, through mucus hypersecretion, still may play a role in the development and progression of bronchiectasis, which ultimately may warrant blocking of both pathways, potentially through upstream alarmins such as TSLP or IL-33.34 This evidence concerns the gene IL5 and bronchiectasis.